Pharmazz, Inc. is a clinical stage pharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target critical care medicine. The company is developing several clinical-stage product candidates, PMZ-2010 (Centhaquine), PMZ-1620 (Sovateltide) and PMZ-2123 for which it holds global marketing rights.